David Sommerhalder, M.D. | Texas Oncology

Dr. David Sommerhalder, MD

Claim this profile

NEXT Oncology

Expert in Solid Tumors
Expert in Cancer
27 reported clinical trials
35 drugs studied

Area of expertise

1

Solid Tumors

Global Leader

David Sommerhalder, MD has run 17 trials for Solid Tumors. Some of their research focus areas include:

Stage IV
Stage III
KRAS positive
2

Cancer

Global Leader

David Sommerhalder, MD has run 13 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
KRAS positive

Affiliated Hospitals

Image of trial facility.

NEXT Oncology

Image of trial facility.

New Experimental Therapeutics Of San Antonio (NEXT Oncology)

Clinical Trials David Sommerhalder, MD is currently running

More about David Sommerhalder, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 27 trials as a Principal Investigator · 12 Active Clinical Trials

Treatments David Sommerhalder, MD has experience with

  • Pembrolizumab
  • AMV564
  • MPT-0118
  • Nab-paclitaxel
  • ORIC-101
  • BBP-398 (Formerly Known As IACS-15509)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does David Sommerhalder, MD specialize in?

Is David Sommerhalder, MD currently recruiting for clinical trials?

Are there any treatments that David Sommerhalder, MD has studied deeply?

What is the best way to schedule an appointment with David Sommerhalder, MD?

What is the office address of David Sommerhalder, MD?

Is there any support for travel costs?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security